CB2 Receptor Agonist Effective for Neuropathic Pain in Preclinical Studies
CNTX-6016, a highly-selective cannabinoid receptor type 2 agonist, was found to provide adequate analgesia in preclinical models of neuropathic pain.
Neuropathic Pain
Benefit of Prompt Corticosteroid Use in Immune Checkpoint Inhibitor-Related Neuropathy
Recognition of the wide phenotype spectrum in immune checkpoint inhibitor-related neuropathy and prompt management with corticosteroids may lead to favorable outcomes.
Pulsed Radiofrequency May Relieve Trigeminal Postherpetic Neuralgia Pain
Computed tomography-guided pulsed radiofrequency therapy may offer pain relief, improve quality of life, and reduce medication use in patients with trigeminal postherpetic neuralgia.
New Urgency for Treating Hereditary ATTR Amyloidosis with Polyneuropathy
Hereditary transthyretin-related amyloidosis (hATTR) with polyneuropathy is a rare, progressive and fatal disease that has been challenging for neurologists to diagnose and manage, until now. Advances in genetic testing have yielded the development of a new generation of more efficient screenings that make early, accurate, and rapid diagnosis more accessible.
Physician Attitudes Toward Herpes Zoster Vaccination Examined Over a Decade of Availability
Only 29% of 2016 survey respondents reported that they strongly agreed that the burden of herpes zoster in patients aged 50 to 59 years old is sufficient to make a vaccine important.
Neuropathic Pain May Not Predict Chronic Widespread Pain in Patients With Regional Pain
The risk for developing chronic widespread pain was found to be comparable in patients with regional pain with or without neuropathic pain.
Perineural Injection of Platelet-Rich Plasma for Peripheral Neuropathy Pain
Perineural injection of platelet-rich plasma may improve pain and numbness associated with diabetic peripheral neuropathy, and enhance peripheral nerve function.
FDA Approves First Generics for Lyrica
The FDA has approved the first generics of Lyrica (pregabalin; Pfizer) capsules.
Addition of Gabapentin to Valacyclovir Does Not Improve Herpes Zoster Pain
The addition of gabapentin to valacyclovir within 72 hours of onset of a herpes zoster rash was not found to provide further relief from acute herpetic pain or to better prevent postherpetic neuralgia.
Diabetic Peripheral Neuropathy Associated With Increased Health Care Costs
Researchers found a substantial cohort of adults with diabetic peripheral neuropathy in the United States with high financial and social costs.
Next post in Neuropathic Pain
